These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10153735)

  • 1. The medical device payment controversy rages on.
    Brown E
    Physician Exec; 1995 Nov; 21(11):40-1. PubMed ID: 10153735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Billing Medicare for investigational devices: what's OK, what's not.
    Gardner JR
    Healthc Financ Manage; 1997 Mar; 51(3):50-4. PubMed ID: 10165439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing efficiency: step by step.
    McGivney WT
    Physician Exec; 1991; 17(4):35-7. PubMed ID: 10112658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blind hog and the acorn: Medicare coverage for investigational devices.
    Betz R
    J Healthc Resour Manag; 1995 Mar; 13(3):31-2. PubMed ID: 10154864
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospitals try to devise solutions in device debate.
    Scott L
    Mod Healthc; 1995 Feb; 25(8):34-6, 38. PubMed ID: 10140204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New obstacles in the path of marketing new medical devices.
    Bucci VA; Reiss JB; Hall NC
    J Health Care Technol; 1985; 2(2):81-96. PubMed ID: 10300491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 1: issues in medical device assessment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Sep; 3(9):694-702. PubMed ID: 17412151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS); clarification of the CHAMPUS exclusion of unproven drugs, devices and medical treatments and procedures--DoD. Final rule.
    Fed Regist; 1997 Jan; 62(3):625-31. PubMed ID: 10164016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HHS probe stirs device controversy.
    Scott L
    Mod Healthc; 1994 Jul; 24(28):54. PubMed ID: 10135039
    [No Abstract]   [Full Text] [Related]  

  • 15. Will insurers pay for high-tech care?
    Crane M
    Med Econ; 1991 Apr; 68(8):82-6. PubMed ID: 10110091
    [No Abstract]   [Full Text] [Related]  

  • 16. Who should be responsible?
    Brown E
    Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532
    [No Abstract]   [Full Text] [Related]  

  • 17. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From medical invention to clinical practice: the reimbursement challenge facing new device procedures and technology--part 3: payment.
    Raab GG; Parr DH
    J Am Coll Radiol; 2006 Nov; 3(11):842-50. PubMed ID: 17412183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reimbursing new technologies: why are the courts judging experimental medicine?
    Saver RS
    Stanford Law Rev; 1992 May; 44(5):1095-131. PubMed ID: 10119850
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical devices: cardiovascular devices: reclassification of the arrhythmia detector and alarm. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Oct; 68(208):61342-4. PubMed ID: 14584507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.